Results 141 to 150 of about 12,342,164 (400)
Molecular Oncology, EarlyView.This study investigates gene expression differences between two major pediatric acute lymphoblastic leukemia (ALL) subtypes, B‐cell precursor ALL, and T‐cell ALL, using a data‐driven approach consisting of biostatistics and machine learning methods. Following analysis of a discovery dataset, we find a set of 14 expression markers differentiating the ...
Mona Nourbakhsh +8 more
wiley +1 more source
AUTORADIOGRAPHIC STUDIES ON THE IMMUNE RESPONSE [PDF]
, 1962 O. Mäkelä, G. J. V. Nossal
openalex +3 more sources
Chemokines and the immune response to cancer.
Immunity, 2021 A. Ozga, Melvyn T. Chow, A. Luster
semanticscholar +1 more source
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Frontiers in Immunology, 2018 Among cells present in the tumor microenvironment, activated fibroblasts termed cancer-associated fibroblasts (CAFs), play a critical role in the complex process of tumor-stroma interaction.
Linda Ziani, S. Chouaib, J. Thiery
semanticscholar +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
STUDIES ON THE IMMUNE RESPONSE OF THE RHEUMATIC SUBJECT AND ITS RELATIONSHIP TO ACTIVITY OF THE RHEUMATIC PROCESS. IV. CHARACTERISTICS OF STRAINS OF HEMOLYTIC STREPTOCOCCUS, EFFECTIVE AND NON-EFFECTIVE IN INITIATING RHEUMATIC ACTIVITY 1 [PDF]
, 1935 Alvin F. Coburn, Ruth Pauli
openalex +1 more source
Immune responses to malignancies [PDF]
Journal of Allergy and Clinical Immunology, 2010 Immune responses to tumor-associated antigens (TAs) are often detectable in tumor-bearing hosts, but they fail to eliminate malignant cells or prevent the development of metastases. Patients with cancer generate robust immune responses to infectious agents (bacteria and viruses) perceived as a "danger signal" but only ineffective weak responses to TAs,
openaire +3 more sources
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Nature Network Boston, 2020 Aaron J. Wilk +14 more
semanticscholar +1 more source